Korro Bio, Inc. (KRRO)
11.00
-0.41
(-3.59%)
USD |
NASDAQ |
Mar 19, 14:16
Korro Bio Total Liabilities (Quarterly) : 64.27M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cencora, Inc. | 76.27B |
| BioCryst Pharmaceuticals, Inc. | 633.31M |
| United Therapeutics Corp. | 872.90M |
| Collegium Pharmaceutical, Inc. | 1.384B |
| ProKidney Corp. | 33.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.71M |
| Shareholders Equity (Quarterly) | 51.44M |
| Debt to Equity Ratio | 0.8454 |
| Current Ratio | 6.901 |
| Net Debt Paydown Yield | -0.45% |